In 2017, Ozempic was approved by the FDA for weight loss and managing type 2 diabetes. The drug, containing semaglutide, was found to potentially help individuals with Polycystic Ovarian Syndrome (PCOS), a hormonal issue affecting women.
PCOS can lead to weight gain, insulin resistance, and heart disease. Ozempic, known for regulating blood sugar, could offer relief for PCOS symptoms by increasing insulin sensitivity and aiding in weight loss. However, it is crucial to consult with a doctor before starting any new medication regimen.
